Boston Partners purchased a new stake in Crocs, Inc. (NASDAQ:CROX – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 74,948 shares of the textile maker’s stock, valued at approximately $10,771,000. Boston Partners owned about 0.12% of Crocs as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. WIT Partners Advisory Pte. Ltd. purchased a new stake in Crocs during the 4th quarter worth approximately $266,431,000. Coatue Management LLC grew its stake in Crocs by 836.7% during the 4th quarter. Coatue Management LLC now owns 1,029,765 shares of the textile maker’s stock valued at $96,190,000 after purchasing an additional 919,835 shares during the last quarter. Norges Bank acquired a new position in shares of Crocs in the fourth quarter valued at about $72,211,000. Patient Capital Management LLC purchased a new position in shares of Crocs in the fourth quarter worth about $39,420,000. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Crocs by 46.7% during the fourth quarter. Goldman Sachs Group Inc. now owns 770,281 shares of the textile maker’s stock worth $71,952,000 after purchasing an additional 245,240 shares during the period. Institutional investors and hedge funds own 93.44% of the company’s stock.
Insider Buying and Selling at Crocs
In other Crocs news, Director Thomas J. Smach sold 10,174 shares of Crocs stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $140.32, for a total value of $1,427,615.68. Following the completion of the transaction, the director now directly owns 115,339 shares of the company’s stock, valued at approximately $16,184,368.48. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, Director Thomas J. Smach sold 10,174 shares of the stock in a transaction on Friday, May 10th. The stock was sold at an average price of $140.32, for a total value of $1,427,615.68. Following the sale, the director now directly owns 115,339 shares in the company, valued at $16,184,368.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Anne Mehlman sold 7,150 shares of the business’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $159.01, for a total value of $1,136,921.50. Following the transaction, the executive vice president now directly owns 143,075 shares of the company’s stock, valued at $22,750,355.75. The disclosure for this sale can be found here. Insiders have sold a total of 30,178 shares of company stock valued at $4,597,445 over the last quarter. 2.72% of the stock is owned by company insiders.
Crocs Trading Down 5.7 %
Crocs (NASDAQ:CROX – Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The textile maker reported $4.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.59 by $0.42. Crocs had a return on equity of 53.20% and a net margin of 20.02%. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period last year, the company earned $3.59 EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis. As a group, equities research analysts predict that Crocs, Inc. will post 12.73 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several brokerages recently issued reports on CROX. Raymond James cut shares of Crocs from a “strong-buy” rating to an “outperform” rating and set a $164.00 target price for the company. in a report on Friday. OTR Global raised Crocs from a “mixed” rating to a “positive” rating in a report on Thursday, April 11th. Wedbush reaffirmed an “outperform” rating and set a $170.00 target price on shares of Crocs in a report on Monday, July 29th. Barclays lowered their price target on shares of Crocs from $169.00 to $164.00 and set an “overweight” rating on the stock in a report on Friday. Finally, UBS Group lowered their target price on shares of Crocs from $148.00 to $146.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 16th. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $154.09.
Get Our Latest Analysis on Crocs
Crocs Profile
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
Featured Stories
- Five stocks we like better than Crocs
- Are Penny Stocks a Good Fit for Your Portfolio?
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- What is a Dividend King?
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.